Clorox (CLX) has come under pressure recently, with the share price down 17% over the past month and 9% in the past 3 months. This has put the consumer staples group back under the microscope for investors.
Zooming out, Clorox’s 1-year total shareholder return is down 25.63%, and the 3-year and 5-year total shareholder returns are also lower. This suggests that recent weakness in the share price is part of a longer period of fading momentum around the stock.
Compare Clorox’s recent slide with a curated set of consumer staples and defensive stocks by scanning 11 resilient stocks with low risk scores that may offer steadier return profiles in volatile periods.
Clorox still owns a shelf full of household brands, yet the share price has been marked down hard. After this reset, are you looking at a solid franchise on sale, or a stock that still asks too much?
Most Popular Narrative: 13.7% Undervalued
On the most followed narrative, Clorox screens below an estimated fair value of $101.71 compared with the last close near $87.76. This sets up a story driven heavily by earnings power and how long that strength can last.
The full-scale implementation of a modern ERP system is expected to drive long-term operational efficiencies by improving supply chain visibility, speeding innovation cycles, and reducing structural costs. These changes should support margin expansion and sustained earnings growth once short-term transition noise normalizes.
Want to see what sits behind that efficiency push and margin story? The fair value reflects assumptions about the pace of profit growth, the future valuation multiple, and the durability of those assumptions.
If you want to go deeper into how this valuation ties into growth, risks, and management, See our AI narrative and valuation for Clorox.
To understand how that potential value intersects with fundamentals and capital structure, including debt coverage and cash flows, it also helps to weigh the key upsides and hazards flagged in the broader work on Clorox, including 2 key rewards and 2 important warning signs
Result: Fair Value of $101.71 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
Still, Clorox’s heavy reliance on a few premium brands, along with rising price competition in categories like Glad and cat litter, could pressure margins and unsettle that valuation story.
Find out about the key risks to this Clorox narrative.
Next Steps
Sentiment around Clorox is clearly mixed, with both concerns and positive factors in play. It may be useful to review the situation promptly and weigh the evidence yourself using 2 key rewards and 2 important warning signs
Looking for more investment ideas beyond Clorox?
If you are weighing what to do with Clorox, do not stop there. Use this moment to scan other opportunities and make your watchlist work harder.
- Target resilience by reviewing list of solid balance sheet and fundamentals (23 results). These can help anchor a portfolio when conditions turn choppy.
- Hunt for mispriced quality and check 16 high quality undiscovered gems before attention and liquidity push valuations away from you.
- Strengthen your income stream and compare potential yield workhorses through 6 dividend fortresses while prices and payouts still look appealing.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com